The job cuts continue at Rockville-based Human Genome Sciences as the biotechnology company folds its employees and operations into those of the British drugmaker that bought the firm this summer. The latest round of cuts targets 97 employees who were notified of the decision last week. The firm also warned that additional reductions would be … Continue reading